Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination

被引:20
作者
Kim, KS [1 ]
Chun, YS [1 ]
Chon, SU [1 ]
Suh, JK [1 ]
机构
[1] Hanyang Univ Hosp, Dept Anaesthesiol, Songdong Ku, Seoul 133792, South Korea
关键词
neuromuscular relaxants; cisatracurium; mivacurium; atracurium; vecuronium; rocuronium; drug interactions;
D O I
10.1046/j.1365-2044.1998.00492.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We compared the dose-response relationships of cisatracurium, mivacurium, atracurium, vecuronium and rocuronium and examined the interactions of cisatracurium with mivacurium, atracurium, vecuronium and rocuronium in humans by isobolographic and fractional analyses. We studied 180 adult patients during nitrous oxide-fentanyl-propofol anaesthesia. Neuromuscular block was monitored using mechanomyography to detect the twitch response of the ulnar nerve at the wrist. The dose-response curves were determined by probit analysis. The calculated ED50 values and their 95% confidence intervals were 40.9 (38.1-43.7), 49.8 (47.0-52.6), 187.2 (175.1-199.3), 36.6 (34.7-38.5) and 136.4 (129.2-143.6) mu g.kg(-1) for cisatracurium, mivacurium, atracurium, vecuronium and rocuronium, respectively. Corresponding ED95 values were 57.6 (53.5-61.7), 91.8 (88.1-95.5), 253.1 (238.9-267.3), 52.9 (49.1-56.7) and 288.7 (276.2-301.2) mu g.kg(-1), respectively. The interaction between cisatracurium and mivacurium, vecuronium or rocuronium was found to be synergistic, but the interaction between cisatracurium and atracurium was found to be additive. Synergy between cisatracurium and vecuronium or rocuronium was greater than between cisatracurium and mivacurium.
引用
收藏
页码:872 / 878
页数:7
相关论文
共 37 条
  • [1] CLINICAL-PHARMACOLOGY OF MIVACURIUM CHLORIDE (BW-B1090U) INFUSION - COMPARISON WITH VECURONIUM AND ATRACURIUM
    ALI, HH
    SAVARESE, JJ
    EMBREE, PB
    BASTA, SJ
    STOUT, RG
    BOTTROS, LH
    WEAKLY, JN
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1988, 61 (05) : 541 - 546
  • [2] THE CLINICAL NEUROMUSCULAR PHARMACOLOGY OF 51W89 IN PATIENTS WITH RECEIVING NITROUS-OXIDE OPIOID BARBITURATE ANESTHESIA
    BELMONT, MR
    LIEN, CA
    QUESSY, S
    ABOUDONIA, MM
    ABALOS, A
    EPPICH, L
    SAVARESE, JJ
    [J]. ANESTHESIOLOGY, 1995, 82 (05) : 1139 - 1145
  • [3] BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
  • [4] BERNBAUM MC, 1977, J CLIN EXPT IMMUNOLO, V28, P1
  • [5] BRANDOM BW, 1994, ANESTH ANALG, V78, P608
  • [6] Relating isobolograms to response surfaces
    Carter, WH
    [J]. TOXICOLOGY, 1995, 105 (2-3) : 181 - 188
  • [7] CHAPPLE DJ, 1983, BRIT J ANAESTH, V55, pS17
  • [8] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS
    CHOU, TC
    TALALAY, P
    [J]. ADVANCES IN ENZYME REGULATION, 1984, 22 : 27 - 55
  • [9] Diefenbach C, 1997, ANAESTHESIST, V46, P3, DOI 10.1007/s001010050364
  • [10] CLINICAL-PHARMACOLOGY OF ORG NC45 (NORCURONTM) - A NEW NON-DEPOLARIZING MUSCLE-RELAXANT
    FAHEY, MR
    MORRIS, RB
    MILLER, RD
    SOHN, YJ
    CRONNELLY, R
    GENCARELLI, P
    [J]. ANESTHESIOLOGY, 1981, 55 (01) : 6 - 11